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ABSTRACT 
Bone is a highly specialised living tissue and has both mechanical and 
metabolical functions.  Remodelling of the bone ensures a healthy bone mass and is 
regulated by a trio of secreted proteins, namely receptor-activator of NFκB (RANK), 
receptor-activator of NFκB ligand (RANKL) and osteoprotegerin (OPG).  OPG, a 
major regulator of osteoclastogenesis, bone resorption and vascular calcification, is 
produced by various cell types including mesenchymally derived cells, particularly 
osteoblastic cells.   
Wnt signalling also plays a role in maintaining healthy bone mass.  Dickkopf-
1 (DKK-1) is a soluble inhibitor of Wnt signalling and its excessive expression 
contributes to bone loss in rheumatoid arthritis and multiple myeloma.  Recently, 
DKK-1 has been demonstrated to be over-produced in osteoblasts of patients with 
Paget’s disease of bone (PDB).  
 The osteoblastic cell lines MG63 and Saos-2 were subjected to a series of 
different growth factors, hormones and cytokines to investigate the production of 
OPG, DKK-1 and the expression of various Wnt proteins.  These results 
demonstrate that during standard culture conditions, both OPG and DKK-1 
production in osteoblastic cells depend on a factor present in serum.  Serum 
deprivation resulted in the up-regulation of Wnt4 and Wnt11, while down-regulating 
the expression of Wnt7b.  Serum-induced OPG and DKK-1 production and Wnt 
expression was found to be regulated via a number of different signalling pathways. 
   OPG production and expression was stimulated by platelet-derived growth 
factor-AB (PDGF-AB) not only in MG63 and Saos-2 osteosarcoma cells, but also a 
mouse pre-osteoblastic cell line (MC3T3-E1) and human bone marrow stromal cells 
(BMSC).  PDGF-AB was shown to act through the PDGF receptor, PKC, PI3K, ERK 
and P38 and not via NFκB or JNK.  PDGF isoforms AA, BB and AB demonstrated a 
similar stimulation of OPG production.  The importance of PDGF in fracture healing 
suggests a role for OPG production in countering bone resorption during the early 
phase of this process. 
 BIO, an inhibitor of canonical Wnt signalling resulted in the down-regulation 
of DKK-1 and the up-regulation of Wnt5a.  Phorbol ester (PE), a known stimulator of 
PKC resulted in the up-regualtion of DKK-1, Wnt4, Wnt7a and Wnt16.  The effects 
of PE were inhibited by bisindolymaleamide but not staurosporine.  DKK-1 
production, but not expression, was observed to be stimulated by calcium along with 
an up-regulation of Wnt7b and a down-regulation of Wnt10a and Wnt11.  Incubation 
of pre-stimulated cells with Triton-X demonstrated the ability of calcium to increase 
DKK-1 secretion. 
 DKK-1 was shown to be significantly elevated in the serum of PDB patients 
compared to healthy controls and did not correlate with ALP levels.  
Immunohistochemistry demonstrated that DKK-1 production is increased in both 
osteoblasts and fibrotic cells within the marrow cavity in PDB patients compared to 
fracture callus.  ß-catenin was found to be localised to intercellular membranes of 
plump osteoblasts, demonstrating its alternate role as a cell adhesion protein.  DKK-
1 therefore may be a useful biomarker of PDB and that Dkk-1 may play a central 
role in the aetiology of PDB.  
 In summary, the results presented in this thesis have investigated the ways 
in which OPG and DKK-1 production in osteoblastic cells can be modulated with 
various effectors and the effect of Wnt signalling.  These results may therefore be 
beneficial to increase the understanding of bone biology, improve fracture repair and 
generate further research into the role DKK-1 and the osteoblast in the aetiology of 
PDB to enable improved treatments to be developed.  
 
  v
CONTENTS 
 
Acknowledgements           ii 
Declaration            iii 
Abstract            iv  
Contents             v   
List of figures           xi 
List of tables                     xvi 
Abbreviations                  xviii 
Units of measurement                  xxii  
 
Chapter 1 Introduction        1 
 1.1 Bone structure, function and composition   2 
  
 1.2 Cells of the bone       7 
  1.2.1 The Osteoblast      7 
  1.2.2 The Osteocyte      8 
  1.2.3 The Bone Lining Cell      8 
  1.2.4 The Osteoclast      9 
  
 1.3   Bone formation       12 
  1.3.1   Wnt signalling       12 
  1.3.2   Wnt signalling inhibitors     18 
   1.3.2.1    sFRP      18 
   1.3.2.2    WIF-1      18 
   1.3.2.3    DKK-1      19 
   1.3.2.4    Sclerostin      20 
  1.3.3 TGFβ and BMP’s      21 
 
  vi 
 1.4   Bone resorption and remodelling     22 
  1.4.1   RANK, RANKL and OPG in bone remodelling  25 
   1.4.1.1    RANK      25 
   1.4.1.2    RANKL      26 
   1.4.1.3    OPG       26 
  1.4.2 Parathyroid hormone      29 
  1.4.3   1,25(OH)2 vitamin D3      30 
  1.4.4   Calcitonin       30 
  1.4.5   Oestrogen       30 
  1.4.6   Markers for bone remodelling     31 
  
 1.5   Bone disease        34 
  1.5.1   Osteoporosis        34 
  1.5.2   Osteopetrosis        35 
  1.5.3   Paget’s disease of bone     36 
  1.5.4 Multiple myeloma      37 
  1.5.5   Osteosarcoma      38 
  1.5.6 Osteoarthritis and Rheumatoid arthritis   39
   
 1.6 Aims and objectives       40 
 
Chapter 2   Materials and methods      41 
 2.1  Materials        42 
  2.1.1   Cells and cell culture      42 
  2.1.2 Reagents       42 
2.1.3   OPG and DKK-1 enzyme-linked immunosorbant assay 
(ELISA)       43 
2.1.4   RNA extraction and real-time polymerase chain reaction    
(RT-PCR)       43 
  vii 
  2.1.5   Immunolocalisation of DKK-1 and β-catenin   43 
  2.1.6   Equipment       43 
  
 2.2   Methods        44 
  2.2.1   Cell culture       44 
  2.2.2   Cell number – propidium iodide assay   45 
  2.2.3 Alizarin red staining      45 
  2.2.4 Alkaline phosphatase assay     45 
  2.2.5 RNA extraction and RT-PCR     46 
   2.2.5.1 RNA extraction     46 
   2.2.5.2 Reverse transcription     46 
   2.2.5.3 Quantitative / real-time PCR    47 
  2.2.6   Human OPG ELISA      48 
  2.2.7 Human DKK-1 ELISA      49 
  2.2.8 Serum alkaline phosphatase     49 
2.2.9 Formalin-fixed paraffin-embedded (FFPE) tissue samples  
 and immunohistochemistry     50 
  2.2.9.1 Preparation of FFPE samples   50 
2.2.9.2 Immunhistochemical localisation of DKK-1 and          
β-catenin      50 
  2.2.10  Statistical analysis      51 
 
Chapter  3 The effect of FCS on osteoblastic cells    52 
 3.1 The effect of FCS on OPG production    53 
 3.2   The effect of FCS on DKK-1 production and Wnt expression 58 
3.3 Identifying possible candidate effectors responsible for the  
FCS-induced OPG and DKK-1 production   69 
3.3.1 The effect of BMP-2 and BMP-7 on OPG and DKK-1 
production       69 
  viii 
3.3.2 The effect of TGFβ on OPG and DKK-1 production  73 
3.3.3 The effect of Activin A on OPG and DKK-1 production 76 
3.3.4 The effect of TNFα on OPG and DKK-1 production  79 
3.3.5 The effect of insulin on OPG and DKK-1 production  82 
3.3.6 The effect of IGFII on OPG and DKK-1 production  85 
3.3.7 The effect of IL-6 on OPG and DKK-1 production  88 
3.3.8 The effect of FGF-1 on OPG and DKK-1 production  91 
3.3.9 The effect of serotonin, HGF and SCF on OPG and  
DKK-1 production      93 
3.3.10 The effect of Bradykinin on OPG and DKK-1 production 97 
 
Chapter  4  The effect of platelet-derived growth factor on      
osteoprotegerin production in osteoblastic cells              99 
 4.1 The effect of PDGF-AB on OPG and DKK-1 production in 
osteoblastic cells                100 
 4.2 The effect of PDGF on differentiated osteoblastic cells            119 
 
Chapter 5 Mechanisms of DKK-1 production              124 
5.1 The effect of simulating canonical Wnt signalling on             
DKK-1 production and Wnt expression             125 
5.2 The effect of sFRP-1 on DKK-1 production and Wnt           
expression                 127 
 5.3 The role of PKC in DKK-1 production and Wnt expression      129 
5.4 The effect of phorbol ester on DKK-1 production and Wnt 
expression                 132 
 
Chapter 6 The effect of calcium on osteoblastic cells             134 
6.1 The effect of calcium on OPG and DKK-1 production in 
osteoblastic cells                135 
 6.2 The effect of EDTA on OPG and DKK-1 production           137 
  ix 
 6.3 Time course of calcium-induced DKK-1 production           139 
6.4 The effect of signalling inhibitors on calcium-induced  
DKK-1 production                141 
 6.5 The effect of Nifedpine and NPS2390             144 
 6.6 The effect of Ionomycin               146 
 6.7 The effect of calcium on Wnt expression             148 
6.8 The effect of cycloheximide and Triton-X on  
calcium-induced DKK-1 production             151 
 
Chapter 7 DKK-1 and Paget’s disease of bone             154 
 7.1 Dkk-1 in serum of patients with Paget’s disease            155 
7.2 Immunolocalisation of DKK-1 and β-Catenin in patients  
 with Paget’s disease of bone              160   
 
Chapter 8 Discussion                 167 
8.1 OPG and DKK-1 production is dependant upon a factor  
 present in serum                168 
8.2 OPG and DKK-1 production can be regulated by a  
 number of cytokines               177 
 8.3 PDGF-AB stimulates OPG production in osteoblastic cells     187 
 8.4 DKK-1; a product of canonical or non-canonical Wnt  
  signalling?                 192 
 8.5 Calcium-induced secretion of DKK-1             199 
 8.6 Paget’s disease and DKK-1               205 
 8.7 Conclusion                 213 
 8.8 Further work                 216 
   
Reference list                  217 
  x
 
List of publications, presentations and prizes related to this work 
 Abstracts/presentations                255 
 Publications                  256 
 Prizes                   256          
 
Appendix 
  xi 
LIST OF FIGURES 
Chapter 1 
Introduction    
 
Fig 1.1     Diagrammatic representation of a long bone. 5 
Fig 1.2     Diagrammatic representation of a section of bone. 6 
Fig 1.3     Diagram depicting the inter-relationships between osteoblasts and 
blood monocytes during osteoclastogenesis.   
11 
Fig 1.4     Canonical Wnt signalling. 15 
Fig 1.5     Schematic representation of the BMSC differentiation linage.   16 
Fig 1.6     Non-canonical Wnt signalling. 17 
Fig 1.7     Schematic representation of the four stages of a bone remodelling 
cycle.  
24 
Fig 1.8     Diagrammatic representation of a mature OPG monomer.  28 
  
Chapter 3 
The effect of FCS on osteoblastic cells 
 
Fig 3.1     The effect of FCS on OPG production in osteoblastic cells. 54 
Fig 3.2     The effect of various media constituents on OPG production in 
osteoblastic cells. 
55 
Fig 3.3     The effect of pathway inhibitors on OPG production in osteoblastic 
cells.   
57 
Fig 3.4     The effect of FCS starvation on DKK-1 production and Wnt 
expression in osteoblastic cells.   
59 
Fig 3.5     FCS-induced DKK-1 production and signals through Pi3K, ERK and 
P38MAPK. 
61 
Fig 3.6     The effect of pathway inhibitors for PI3K, P38MAPK, JNK and 
ERK/MEK on Wnt expression in osteoblastic cells.   
62 
Fig 3.7    The effect of serum starvation on DKK-1 with time. 65 
Fig 3.8     The effect of serum starvation on the expression of Wnt4, Wnt7b 
and Wnt11 with time.   
66 
Fig 3.9      The effect of re-addition of FCS.   68 
  xii 
Fig 3.10     BMP-2 stimulates both OPG and DKK-1 production in MG63 cells.   70 
Fig 3.11     The effect of BMP-2 on OPG and DKK-1 production in Saos-2 
cells.   
71 
Fig 3.12     The effect of BMP-7 on OPG and DKK-1 production in osteoblastic 
cells.   
72 
Fig 3.13     The effect of TGFβ on OPG and DKK-1 production in MG63 cells.   74 
Fig 3.14     The effect of TGFβ on OPG and DKK-1 production in Saos-2 cells.   75 
Fig 3.15     The effect of Activin A on OPG and DKK-1 production in MG63 
cells.   
77 
Fig 3.16     The effect of Activin A on OPG and DKK-1 production in Saos-2 
cells. 
78 
Fig 3.17     The effect of TNFα on OPG and DKK-1 production in MG63 cells.   80 
Fig 3.18     The effect of TNFα on OPG and DKK-1 production in Saos-2 cells.   81 
Fig 3.19     The effect of insulin on OPG and DKK-1 production in MG63 cells.   83 
Fig 3.20     The effect of insulin on OPG and DKK-1 production in Saos-2 
cells.   
84 
Fig 3.21     The effect of IGFII on OPG and DKK-1 production in MG63 cells.   86 
Fig 3.22     The effect of IGFII on OPG and DKK-1 production in Saos-2 cells.   87 
Fig 3.23     The effect of IL-6 on OPG and DKK-1 production in MG63 cells.   89 
Fig 3.24     The effect of IL-6 on OPG and DKK-1 production in Saos-2 cells.   90 
Fig 3.25     The effect of FGF-1 on OPG and DKK-1 production in osteoblastic 
cells.   
92 
Fig 3.26     The effect of serotonin on OPG and DKK-1 production in 
osteoblastic cells.   
94 
Fig 3.27     The effect of SCF on OPG and DKK-1 production in osteoblastic 
cells.   
95 
Fig 3.28     The effect of HGF on OPG and DKK-1 production in osteoblastic 
cells.   
96 
Fig 3.29     The effect of bradykinin on OPG and DKK-1 production in 
osteoblastic cells.   
98 
  xiii 
Chapter 4 
The effect of platelet-derived growth factor on osteoprotegerin 
production in osteoblastic cells 
 
Fig 4.1      The effect of PGDF-AB on osteoblastic cell proliferation. 101 
Fig 4.2     The effect of PDGF-AB on OPG and DKK-1 production in MG63 
cells. 
102 
Fig 4.3     The effect of PDGF-AB on OPG and DKK-1 production in Saos-2 
cells. 
104 
Fig 4.4     PDGF-AB-induced OPG production in osteoblastic cells is time 
dependent. 
106 
Fig 4.5     All PDGF isoforms stimulate OPG production in osteoblastic cells. 107 
Fig 4.6     PDGF-AB stimulates OPG protein production in MC3T3-E1 and 
hMSC but not in hFOB or skin fibroblasts.   
109 
Fig 4.7    PDGF-AB-stimulated OPG production is inhibited by AG1296.   110 
Fig 4.8    PDGF-AB-stimulated OPG production is accompanied by increased 
mRNA expression and is inhibited by AG1296.   
111 
Fig 4.9     PDGF-AB signals through PI3K, ERK and p38.   113 
Fig 4.10    The effect of STS on cell number in osteoblastic cells.   116 
Fig 4.11    PDGF-AB induced OPG production is stimulated by STS.   117 
Fig 4.12    PDGF-AB induced OPG production is inhibited by BIM.   118 
Fig 4.13    ALP expression in Saos-2 cells with differentiation.   120 
Fig 4.14   The ability for PDGF-AB to stimulate OPG production is lost with 
osteoblastic differentiation.   
121 
Fig 4.15   The expression of the PDGF receptors α and β during 
differentiation.   
123 
  
Chapter 5 
Mechanisms of DKK-1 production 
 
Fig 5.1     The effect of BIO on DKK-1 production and Wnt expression in 
MG63 cells.   
126 
Fig 5.2     The effect of sFRP-1 on Wnt expression and DKK-1 production in 128 
  xiv 
MG63 cells.   
Fig 5.3     The effect of BIM and STS on DKK-1 production in MG63 cells.   130 
Fig 5.4     The effect of BIM and STS on Wnt and DKK-1 expression in MG63 
cells.   
131 
Fig 5.5    The effect of BIM and STS on PE-induced Wnt and DKK-1 
expression in MG63 cells.   
133 
  
Chapter 6 
The effect of calcium on osteoblastic cells  
 
Fig 6.1    The effect of calcium on OPG and DKK-1 production in MG63 cells.   136 
Fig 6.2    The effect of EDTA on OPG and DKK-1 production in MG63 cells. 138 
Fig 6.3     The time course for calcium-induced DKK-1 production in MG63 
cells.   
140 
Fig 6.4     The effect of signalling inhibitors on calcium-induced DKK-1 
production in MG63 cells.   
142 
Fig 6.5     The effect of nifedipine and NPS2390 on calcium-induced DKK-1 
production in MG63 cells.   
145 
Fig 6.6     The effect of ionomycin on calcium-induced DKK-1 production in 
MG63 cells.   
147 
Fig 6.7     The effect of calcium on the expression of Wnt7b, Wnt10a and 
Wnt11 in MG63 cells.   
149 
Fig 6.8     The effect of calcium on the expression of Wnt3a, Wnt4, Wnt5a and 
DKK-1 in MG63 cells. 
150 
Fig 6.9     The effect of cycloheximide on calcium-induced DKK-1 production 
in MG63 cells.   
152 
Fig 6.10   The effect of Triton X-100 on calcium-induced DKK-1 production in 
MG63 cells.   
153 
  
Chapter 7 
DKK-1 and Paget’s disease of bone 
 
Fig 7.1     Log10 tsALP concentration in PDB patients and controls.   157 
  xv 
Fig 7.2     Serum DKK-1 concentration in PDB patients and controls.   159 
Fig 7.3     Key histological observations in FFPE bone sections from PDB 
patients.   
161 
Fig 7.4     Immunolocalisation of DKK-1 in fracture callus and PDB.   162 
Fig 7.5     Immunolocalisation of DKK-1 in fibrotic regions of PDB.   163 
Fig 7.6     Immunolocalisation of β-catenin in fracture callus.   165 
Fig 7.7     Immunolocalisation of β-catenin in PDB.   166 
  
Chapter 8 
Discussion 
 
Fig 8.1     Signalling pathways and their effect on OPG and DKK-1 production, 
DKK-1 expression and Wnt expression in response to serum.   
172 
Fig 8.2    Mechanisms of PDGF-induced OPG production in osteoblastic cells. 188 
Fig 8.3     The regulation of DKK-1 production, DKK-1 expression and Wnt 
expression by PKC 
198 
 
  xvi 
LIST OF TABLES 
Chapter 1 
Introduction  
 
Table 1.1      Indicating the markers of bone formation, bone resorption, and    
where they can be measured. 
33 
  
Chapter 4 
The effect of platelet-derived growth factor on osteoprotegerin 
production in osteoblastic cells 
 
Table 4.1      Signalling inhibitors and OPG production.   114 
  
Chapter 6 
The effect of calcium on osteoblastic cells 
 
Table 6.1      Percentage stimulation of calcium-induced DKK-1 production in 
MG63 cells in the presence of various inhibitors.  
143 
  
Chapter 7 
DKK-1 and Paget’s disease of bone 
 
Table 7.1      Age and study sample size in PDB patients and controls. 156 
  
Chapter 8 
Discussion 
 
Table 8.1      Summary of the signalling inhibitors used in chapter 3 and their   
effect on OPG and DKK-1 production, DKK-1 expression and 
Wnt expression. 
171 
Table 8.2     Summary of the effectors used in chapter 3 and their effect on  
OPG and DKK-1 production in MG63 cells both with and without 
FCS. 
185 
Table 8.3     Summary of the effectors used in chapter 3 and their effect on 
OPG and DKK-1 production in Saos-2 cells both with and 
without FCS. 
186 
  
  xvii 
Table 8.4     Summary of the effectors used in chapter 5 and their effect on 
DKK-1 production, DKK-1 expression and Wnt expression. 
197 
Table 8.5     Summary of the effect of calcium on OPG and DKK-1 production, 
DKK-1 expression and Wnt expression.  
200 
 
 
 
  xviii 
ABBREVIATIONS 
 
1,25(OH)2D3  1,25 dihydroxyvitamin D3 
αMEM   Minimal essential medium, alpha 
ALP   Alkaline phosphatase 
ANOVA  Analysis of variance 
APC   Adenomatous polyposis coli 
ATP   Adenosine triphosphate 
BGP   Sodium beta-glycerophosphate 
BIM   Bisindolylmaleamide 
BIO   6-Bromoindirubin-3’-monoxime 
BMD   Bone mineral density 
BMP-2   Bone morphogenetic protein-2 
BMP-7   Bone morphogenetic protein-7 
BMSC   Bone marrow stromal cell 
BMU   Bone multicellular unit 
BP   Bisphosphonate 
BSA   Bovine serum albumin 
BSP   Bone sialoprotein 
Ca2+   Calcium ions 
CaCl2   Calcium Chloride  
cAMP   Cyclic adenosine monophosphate 
CaSR   Calcium sensing receptor 
cDNA   Copy deoxyribonucleic acid 
CRD   Cysteine-rich domain 
CREB   Cyclic adenosine monophosphate response element-binding 
CT   Cycle threshold 
CTX   Carboxy-terminal crosslinked telopeptide of type I collagen 
DAB   3,3’ diaminobenzidine 
DEXA   Dual energy X-ray absorptiometry 
DKK-1   Dickkopf-1 
DKK-2   Dickkopf-2 
DKK-3   Dickkopf-3 
DKK-4   Dickkopf-4 
DMEM   Dulbecco’s modified essential medium 
DNA   Deoxyribonucleic acid 
  xix 
Dvl   Dishevelled protein 
ECM   Extracellular Matrix 
EDTA   Diaminoethanetetra-acetic acid diammonium salt 
ELISA   Enzyme-linked immunosorbant assay 
ERK   Extracellular signal-related kinase 
ESH   Expansile skeletal hyperphophatasia 
FCS   Foetal calf serum 
FEO   Familial expansile osteolysis 
FFPE   Formalin fixed paraffin embedded 
FGF-1   Fibroblast growth factor-1 
FGF-2   Fibroblast growth factor-2 
Fzd   Frizzled receptor 
GAPDH  Glyceralderhyde-3-phosphate dehydrogenase 
GH   Growth hormone 
GHSH   Growth hormone stimulating hormone 
GIOP   Glucocorticoid induced osteoporosis 
GS3Kβ  Glycogen synthase kinase-3 beta 
HCl   Hydrochloric acid 
hESC   Human embryonic stem cell 
HGF   Hepatocyte growth factor 
hMSC   Human mesenchymal stems cell 
HSPG   Heparin sulphate proteoglycan 
IGFII   Insulin-like growth factor-II 
IL-1   Interleukin-1 
IL-6   Interleukin-6 
IL-11   Interleukin-11 
JNK   c-Jun N-terminal kinase 
JPD   Juvenile Paget’s disease of bone 
LEF   Lymphoid enhancing factor 
LRP5/6  Low density lipoprotein related protein 5/6 
M-CSF   Macrophage-colony stimulating factor 
MM   Multiple myeloma 
MMP-13  Matrix metalloproteinase-13 
mRNA   Messenger ribonucleic acid 
MSC   Mesenchymal stem cell 
n   Number of replicates 
ND   Not detected 
  xx 
NF-AT   Nuclear factor of activated T-cells 
NFκB   Nuclear-factor kappa B 
NHS   National health service 
NTX   Amino-terminal crosslinked telopeptide of type I collagen  
OA   Osteoarthiritis 
OC   Osteocalcin 
OCIF   Osteoclastogenesis inhibitory factor 
ODAR   Osteoclast differentiation and activation receptor 
ODF   Osteoclast differentiation factor 
OPG   Osteoprotegerin 
OPGL   Osteoprotegerin ligand 
OPPG   Osteoporosis pseudoglioma 
P   Probability factor 
p38 MAPK  p38 mitogen-activated protein kinase 
PAR-2   Protease-activated receptor-2 
PBS   Phosphate buffered saline 
PCP   Planar cell polarity 
PCR   Polymerase chain reaction 
PDB   Paget’s disease of bone 
PDGF-AA  Platelet-derived growth factor-AA 
PDGF-AB  Platelet-derived growth factor-AB 
PDGF-BB  Platelet-derived growth factor-BB 
PDGFRα  Platelet-derived growth factor receptor alpha 
PDGFRβ  Platelet-derived growth factor receptor beta 
PE   Phorbol ester 
PGE2   Prostaglandin E2 
PI   Propidium iodide 
Pi3K   Phosphoinositide-3OH kinase 
PICP   Carboxy-terminal propeptide of type I procollagen 
PINP   Amino-terminal propeptide of type I procollagen 
PKA   Protein kinase A 
PKC   Protein kinase C 
PTH   Parathyroid hormone 
RA   Rheumatoid arthritis  
RANK   Receptor activator of nuclear-factor kappa B 
RANKL  Receptor activator of nuclear-factor kappa B ligand 
RNA   Ribonucleic acid 
  xxi 
RT-PCR  Reverse transcription polymerase chain reaction 
SCF   Stem cell factor 
SD   Standard deviation 
sFRP-1  Secreted Frizzled-related protein-1 
sFRP-2  Secreted Frizzled-related protein-2 
sFRP-3  Secreted Frizzled-related protein-3 
sFRP-4  Secreted Frizzled-related protein-4 
siRNA   Short interfering ribonucleic acid 
SOST   Sclerostin 
SQSTM1  Sequestosome 1 
sRANKL  Soluble RANKL 
STS   Staurosporine 
TACE   TNF-α convertase enzyme 
TBS   Tris buffered saline 
TCF   T-cell factor 
TGFβ   Transforming growth factor-beta 
TMB   3,3’5,5’ tetramethylbenzidine 
TNFR   Tumour necrosis factor receptor 
TNFα   Tumour necrosis factor-alpha 
Tph1   Tryptophan hydroxyalse I 
TRAIL   TNF-related apoptosis-inducing ligand 
TRANCE  TNF-related activation-induced cytokine 
TRAP   Tartrate resistant acid phosphatase 
tsALP   Total serum alkaline phosphatase 
UBA   Ubiquitin-associated 
VDR   Vitamin D receptor 
VEGF   Vascular endothelial growth factor 
VSCC   Voltage-sensitive calcium channel 
WIF-1   Wnt inhibitory factor-1 
WISP   Wnt-induced secreted protein 
   
  xxii 
UNITS OF MEASUREMENT 
 
g   Gravitational force 
g   Gram 
mg   Milligram 
µg   Microgram 
ng   Nanogram 
L   Litre 
mL   Millilitre 
µL   Microlitre 
M   Molar 
mM   Millimolar 
µM   Micromolar 
nM   Nanomolar 
cm   Centimetre 
mm   Millimetre 
µm   Micrometre 
nm   Nanometre 
U/ml   Units per millilitre 
 
 
  
 
